Today: 17 April 2026
Subscribe
Browse Category

Artificial Intelligence 10 January 2026 - 11 January 2026

Shopify stock set for Monday test after Google AI shopping protocol reveal

Shopify stock set for Monday test after Google AI shopping protocol reveal

Shopify and Google announced a new “Universal Commerce Protocol” on Sunday, enabling AI agents to complete purchases inside chat tools like Google Search’s AI Mode and Gemini. Shopify shares closed down 2.26% at $164.48 on Friday, despite the S&P 500 hitting a record high. Google CEO Sundar Pichai said the protocol is open and backed by major retailers. Traders await Monday’s open and U.S. inflation data on Tuesday.
11 January 2026
··
China Mobile Limited Class A stock (600941) on watch: AI “infrastructure edge” talk meets China data week

China Mobile Limited Class A stock (600941) on watch: AI “infrastructure edge” talk meets China data week

China Mobile’s Class A shares closed flat at 100.12 yuan in Shanghai Monday. Weekend remarks from Chinese AI experts highlighted China’s edge in electricity and network infrastructure, drawing investor focus to telecom stocks. Key December trade and credit data are due later this week. China reported 4.83 million 5G base stations and 1.19 billion 5G users by November.
11 January 2026
···
Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Tencent Holdings stock: buyback keeps pressure on bears as AI bottleneck warning hits tape

Tencent repurchased 1,039,000 shares on Jan. 9 for HK$635.9 million, a filing showed, bringing total buybacks under its current mandate to over 108 million shares. The stock closed at HK$611, down 0.81%, underperforming the Hang Seng Tech Index. Tencent cannot issue new shares until Feb. 8. Shares resume trading Monday amid continued volatility in China’s tech sector.
11 January 2026
···
Oracle stock pops nearly 5% into weekend — what’s next for ORCL after Stargate AI buildout and board exits

Oracle stock pops nearly 5% into weekend — what’s next for ORCL after Stargate AI buildout and board exits

Oracle shares surged 4.7% to $198.52 on Friday, outpacing the S&P 500’s 0.65% gain. Directors George Conrades and Naomi Seligman retired after nearly two decades, according to a regulatory filing. Oracle’s role in the Stargate AI data-center project drew attention after OpenAI and SoftBank pledged $1 billion for expansion. Trading resumes Monday after the weekend market closure.
11 January 2026
···
SoundHound AI stock jumps 7% ahead of Monday as CES demos and TomTom tie-up keep SOUN in focus

SoundHound AI stock jumps 7% ahead of Monday as CES demos and TomTom tie-up keep SOUN in focus

SoundHound AI shares jumped 6.7% to $11.75 Friday, trading nearly 39.3 million shares after the company showcased new “agentic” voice commerce features at CES 2026. TomTom announced a partnership with SoundHound for in-car voice assistants. DA Davidson cut its price target, and short interest stands near 30.6%. SoundHound has not set its next earnings date.
11 January 2026
···
BlackRock’s 2026 playbook: AI still leads, but cash income fades and diversification returns

BlackRock’s 2026 playbook: AI still leads, but cash income fades and diversification returns

BlackRock strategists expect the AI-driven market rally to continue into 2026 but urge investors to diversify beyond mega-cap tech stocks. The firm warns long-term U.S. Treasuries are becoming less reliable as a hedge and highlights falling cash yields as central banks cut rates. BlackRock recommends shifting toward income-generating assets, including intermediate bonds and international stocks.
11 January 2026
·
SoundHound AI stock jumps into the weekend after D.A. Davidson trims target; traders eye Monday

SoundHound AI stock jumps into the weekend after D.A. Davidson trims target; traders eye Monday

SoundHound AI shares surged 6.7% to $11.75 Friday, rebounding from early losses after DA Davidson cut its price target to $14, citing execution risks. Trading volume hit 39.3 million shares, and options activity spiked. The move followed CES meetings and new product demos. U.S. markets reopen Monday, with traders watching for follow-through.
11 January 2026
··
IBM stock in focus: new edge-AI rollout, CPI next week and Jan. 28 earnings ahead

IBM stock in focus: new edge-AI rollout, CPI next week and Jan. 28 earnings ahead

IBM shares closed Friday up 0.5% at $304.22 after trading between $301.14 and $306.90. Datavault AI said it will expand its partnership with IBM to launch an edge AI network in New York and Philadelphia using IBM’s watsonx. Investors await U.S. CPI data on Jan. 13 and IBM’s quarterly results on Jan. 28. IBM’s 52-week range is $214.50 to $324.90.
10 January 2026
···
Caterpillar stock gains after CES AI assistant push; CPI and earnings are next test

Caterpillar stock gains after CES AI assistant push; CPI and earnings are next test

Caterpillar shares rose 1.6% to $617.62 Friday after the company showcased its new Cat AI Assistant and automation initiatives at CES in Las Vegas. The system, developed with Nvidia, is being piloted on excavators and aims to streamline equipment management. About 1.8 million shares traded. Investors now await Jan. 13 U.S. CPI data and upcoming Fed policy signals.
10 January 2026
···
Nvidia stock hits a China payment snag on H200 AI chips — what to watch before markets reopen

Nvidia stock hits a China payment snag on H200 AI chips — what to watch before markets reopen

Nvidia now requires full upfront payment from Chinese buyers of its H200 AI chips, sources said, tightening terms amid regulatory scrutiny. Chinese firms have ordered over 2 million units, far above Nvidia’s available stock of 700,000. Nvidia shares closed down 0.1% at $184.86 Friday. AI chip stocks ended mixed as the S&P 500 and semiconductor index hit new records.
10 January 2026
···
Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly shares fell 2% to $1,063.56 Friday, extending a two-day decline and lagging the broader market. The drop followed late-stage trial results for a Zepbound-Taltz drug combo and news of a $1.2 billion deal to buy Ventyx Biosciences. A Form 4 filing showed Lilly Endowment sold 292,148 shares on January 7. Lilly will present at the J.P. Morgan Healthcare Conference on January 13.
10 January 2026
···
Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft shares rose 0.2% to $479.28 Friday after the company launched Copilot Checkout and new “agentic AI” tools for retailers. PayPal will handle payments for the new platform. The S&P 500 closed at a record high, up 0.6%. U.S. CPI data is due Jan. 13, with Microsoft’s Q2 earnings set for Jan. 28.
10 January 2026
·····
SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI shares closed up 6.7% at $11.75 Friday, with 39.3 million shares traded after CES product demos and news of a TomTom partnership. DA Davidson cut its price target to $14, while Oppenheimer and Cantor Fitzgerald maintained their ratings. The stock finished below key moving averages. Investors await Tuesday’s U.S. CPI data and SoundHound’s next earnings report, estimated for Feb. 26.
10 January 2026
··
Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Schrödinger will integrate Eli Lilly’s AI drug discovery platform, TuneLab, into its LiveDesign software, giving biotech teams direct access to Lilly’s predictive models. Revvity and Benchling also announced deals to offer TuneLab through their platforms. Lilly and Revvity will jointly fund access for select users, using federated learning to protect data. BigHat Biosciences will collaborate with Lilly to improve antibody developability models.
10 January 2026
····
1 … 49 50 51 52 53 … 166

Stock Market Today

  • Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models
    April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast, a discounted cash flow (DCF) model values shares at $47.64, signaling overvaluation based on cash flow projections. This valuation split highlights uncertain assumptions about Symbotic's ability to translate its backlog into sustainable cash earnings, with risks including customer concentration and contract delays.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 17.04.2026

17 April 2026
LIVEMarkets rolling coverageStarted: April 17, 2026, 12:00 AM EDTUpdated: April 17, 2026, 4:47 AM EDT Symbotic (SYM) Valuation Shows Mixed Signals Amid Strong Backlog and Cash Flow Models April 17, 2026, 4:47 AM EDT. Symbotic (SYM) shares hover near $60.56 after a strong 197% total return over the past year and 19.9% revenue growth. The company boasts a record $22.4 billion backlog, reflecting robust demand for its warehouse automation systems amid rising e-commerce adoption. Analysts' valuation models diverge: a narrative-based fair value of $64.05 suggests the stock is 5.4% undervalued, relying on rapid backlog conversion and margin expansion. In contrast,
Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop